Search for: "In Re: Katelyn R. et al." Results 1 - 1 of 1
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2020, 3:00 pm by Kevin LaCroix
  In In re: Nektar Therapeutics, the plaintiffs have so far failed to justify adequate reliance on a short-seller report to substantiate allegations of fraud on the market. [read post]